New tests for breast cancer risk mutations beyond the well–known breast cancer genes would offer actionable information for many women and their doctors, a new study finds. Reuters Health, 08/13/2015. (Also see Cancer)
This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.